Decreased miR-340 Expression in Bone Marrow Is Associated with Liver Metastasis of Colorectal Cancer
暂无分享,去创建一个
K. Mimori | H. Ishii | Y. Doki | M. Mori | I. Takemasa | T. Mizushima | M. Ohue | Y. Miyake | Hirofumi Yamamoto | H. Takeyama | J. Nishimura | N. Haraguchi | K. Murata | R. Suzuki | S. Yamashita | Takeshi Kato | Xin Wu | H. Takahashi
[1] V. Spiegelman,et al. MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor mRNA is inhibited by the coding region determinant-binding protein. , 2014, The Journal of Biological Chemistry.
[2] Jan Lubinski,et al. MiRNA‐362‐3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer , 2013, International journal of cancer.
[3] P. Tan,et al. Identification of Circulating MicroRNA Signatures for Breast Cancer Detection , 2013, Clinical Cancer Research.
[4] Y. Doki,et al. Fabrication and Intracellular Delivery of Doxorubicin/Carbonate Apatite Nanocomposites: Effect on Growth Retardation of Established Colon Tumor , 2013, PloS one.
[5] K. Gopinath,et al. Oncogenic MicroRNA-155 Down-regulates Tumor Suppressor CDC73 and Promotes Oral Squamous Cell Carcinoma Cell Proliferation , 2012, The Journal of Biological Chemistry.
[6] C. Marsden,et al. Disseminated Breast Cancer Cells Acquire a Highly Malignant and Aggressive Metastatic Phenotype during Metastatic Latency in the Bone , 2012, PloS one.
[7] Yu Hu,et al. miR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect. , 2012, Oncology reports.
[8] K. Mimori,et al. Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases , 2012, British Journal of Cancer.
[9] E. Morii,et al. MicroRNA-mediated upregulation of integrin-linked kinase promotes Src-induced tumor progression , 2012, Oncogene.
[10] Xiao-nan Wang,et al. miR‐340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c‐Met , 2011, Cancer.
[11] B. Trink,et al. Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cells , 2011, Cell Death and Differentiation.
[12] Ru-Fang Yeh,et al. TRPS1 Targeting by miR-221/222 Promotes the Epithelial-to-Mesenchymal Transition in Breast Cancer , 2011, Science Signaling.
[13] J. Nesland,et al. Disseminated tumour cells as a prognostic biomarker in colorectal cancer , 2011, British Journal of Cancer.
[14] K. Kelnar,et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. , 2011, Nature medicine.
[15] L. Vermeulen,et al. Cancer stem cell niche: the place to be. , 2011, Cancer research.
[16] T. Akaike,et al. Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[17] Suman Lee,et al. Induction of growth arrest by miR‐542‐3p that targets survivin , 2010, FEBS letters.
[18] Klaus Pantel,et al. Circulating tumour cells in cancer patients: challenges and perspectives. , 2010, Trends in molecular medicine.
[19] K. Kelnar,et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. , 2010, Cancer research.
[20] L. Terracciano,et al. Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer , 2010, British Journal of Cancer.
[21] V. Spiegelman,et al. MicroRNA-340-mediated Degradation of Microphthalmia-associated Transcription Factor mRNA Is Inhibited by the Coding Region Determinant-binding Protein* , 2010, The Journal of Biological Chemistry.
[22] M. Ellis,et al. Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial. , 2010, The Lancet. Oncology.
[23] Shuai Jiang,et al. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. , 2010, Cancer research.
[24] Ming Yao,et al. Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA , 2010, Nature Cell Biology.
[25] E. Barillot,et al. miR-181a and miR-630 regulate cisplatin-induced cancer cell death. , 2010, Cancer research.
[26] Hansjuerg Alder,et al. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. , 2009, Cancer cell.
[27] J. Köllermann,et al. Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] F. Barany,et al. c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases. , 2008, Cancer letters.
[29] K. Mimori,et al. Hematogenous Metastasis in Gastric Cancer Requires Isolated Tumor Cells and Expression of Vascular Endothelial Growth Factor Receptor-1 , 2008, Clinical Cancer Research.
[30] S. K. Zaidi,et al. MicroRNAs 221 and 222 bypass quiescence and compromise cell survival. , 2008, Cancer research.
[31] F. Slack,et al. The let-7 microRNA reduces tumor growth in mouse models of lung cancer , 2008, Cell cycle.
[32] Ladan Fazli,et al. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development , 2007, Proceedings of the National Academy of Sciences.
[33] Giovanni Vanni Frajese,et al. miR-221 and miR-222 Expression Affects the Proliferation Potential of Human Prostate Carcinoma Cell Lines by Targeting p27Kip1* , 2007, Journal of Biological Chemistry.
[34] Jaw-Yuan Wang,et al. Multiple Molecular Markers as Predictors of Colorectal Cancer in Patients with Normal Perioperative Serum Carcinoembryonic Antigen Levels , 2007, Clinical Cancer Research.
[35] R. Ach,et al. Direct and sensitive miRNA profiling from low-input total RNA. , 2006, RNA.
[36] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[37] A. Giuliano,et al. Most Early Disseminated Cancer Cells Detected in Bone Marrow of Breast Cancer Patients Have a Putative Breast Cancer Stem Cell Phenotype , 2006, Clinical Cancer Research.
[38] A. Maruyama,et al. pH-sensing nano-crystals of carbonate apatite: effects on intracellular delivery and release of DNA for efficient expression into mammalian cells. , 2006, Gene.
[39] M Vasei,et al. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers , 2006, British Journal of Cancer.
[40] T. Fehm,et al. A pooled analysis of bone marrow micrometastasis in breast cancer. , 2005, The New England journal of medicine.
[41] T. Gruenberger. Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases , 2005, European Surgery.
[42] V. Ambros. The functions of animal microRNAs , 2004, Nature.
[43] Ruud H. Brakenhoff,et al. Dissecting the metastatic cascade , 2004, Nature Reviews Cancer.
[44] M. Monden,et al. JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1. , 2003, Gastroenterology.
[45] H. Kato,et al. Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected nonsmall cell lung cancer: a multicenter prospective study. , 2003, The Annals of thoracic surgery.
[46] M. Monden,et al. Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] G Kvalheim,et al. Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[48] M. Salgaller. American Association for Cancer Research , 2000, Expert opinion on investigational drugs.
[49] M. Banerjee,et al. Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[50] K. Pantel,et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases , 1996, The Lancet.
[51] Yusuke Yamamoto,et al. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[52] René Bernards,et al. A progression puzzle. , 2002, Nature.